-
27 May 2025 14:43:22
- Source: Sharecast
Verici Dx plc
("Verici Dx" or the "Company")
Result of General Meeting
Verici Dx Plc, (AIM: VRCI), a developer of advanced clinical diagnostics for organ transplant, announces that at the General Meeting ("GM") held earlier today, all resolutions, as set out in the GM notice published on 9 May 2025, were duly passed on a poll. Resolution 1 was passed as an ordinary resolution and resolution 2 was passed as a special resolution.
The voting results of the GM were as follows:
|
|
In Favour |
Against |
Withheld |
||
|
Resolution |
Votes |
% |
Votes |
% |
Votes |
|
1 |
112,453,134 |
99.96 |
47,616 |
0.04 |
23,820 |
|
2 |
112,380,881 |
99.89 |
119,738 |
0.11 |
23,951 |
|
Verici Dx plc
|
www.vericidx.com |
|
|
Sara Barrington, CEO |
Via Walbrook PR |
|
|
|
|
|
|
Singer Capital Markets (Nominated Adviser and Broker) |
Tel: +44 (0)20 7496 3000 |
|
|
Phil Davies / Sam Butcher |
|
|
|
|
|
|
|
Walbrook PR (Media & Investor Relations) |
Tel: +44 (0)20 7933 8780 or vericidx@walbrookpr.com |
|
|
Alice Woodings / Paul McManus |
Mob: +44 (0)7407 804 654 / +44 (0)7980 541 893 |
|
|
|
|
|
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.